We compared two recombinant human tissue factor (r-TF) prothrombin tim
e (PT) reagents with two commercially available mammalian PT reagents.
The two r-TF reagents were more sensitive to the lower concentrations
of factors II, VII, IX, and X. The r-TF preparations were found to gi
ve longer clotting times than the mammalian thromboplastins when plasm
a samples from oval anticoagulant-treated patients were tested. When i
nternational normalized ratios (INRs) were calculated, however, no sig
nificant differences were noted among reagents when INR values were le
ss than or equal to 3.0; however, at INR values greater than 3.0, diff
erences were noted. The r-TF was more sensitive to the thrombin inhibi
tors than were heparins. Because of different origins and composition,
the currently available thromboplastin reagents are not equivalent, a
nd the results obtained from these should be interpreted carefully.